Swisse Ultiboost Menopause Balance

Country: Awstralja

Lingwa: Ingliż

Sors: Department of Health (Therapeutic Goods Administration)

Ixtrih issa

Ingredjent attiv:

Glycine max, Quantity: 86.25 mg (Equivalent: Glycine max, Qty 13.8 g); Salvia officinalis, Quantity: 236.36 mg (Equivalent: Salvia officinalis, Qty 1.3 g; Equivalent: thujone, Qty 0.24 mg); Actaea racemosa, Quantity: 4 mg (Equivalent: Actaea racemosa, Qty 20 mg); calcium citrate tetrahydrate, Quantity: 771.04 mg (Equivalent: calcium, Qty 162.5 mg); colecalciferol, Quantity: 0.0125 mg

Disponibbli minn:

Swisse Wellness Pty Ltd

Għamla farmaċewtika:

Tablet, film coated

Kompożizzjoni:

Excipient Ingredients: Carnauba Wax; povidone; colloidal anhydrous silica; magnesium stearate; croscarmellose sodium; crospovidone; microcrystalline cellulose; maltodextrin; titanium dioxide; purified talc; polyvinyl alcohol; macrogol 3350; copper chlorophyllin; maize starch; Acacia; silicon dioxide; dl-alpha-tocopherol; sucrose; medium chain triglycerides

Rotta amministrattiva:

Oral

Indikazzjonijiet terapewtiċi:

Decrease/reduce/relieve excessive perspiration/sweating ; Maintain/support general health and wellbeing ; Maintain/support healthy teeth ; Maintain/support teeth strength ; Maintain/support bone health ; Maintain/support bone strength ; A diet deficient in calcium can lead to osteoporosis in later life. Calcium may help prevent osteoporosis when dietary intake is inadequate ; Vitamin D helps calcium absorption (or words of like intent) and a diet deficient in calcium can lead to osteoporosis in later life ; Helps prevent dietary (state vitamin/mineral/nutrient) deficiency ; Decrease/reduce/relieve sleeplessness ; Helps decrease/reduce/relieve night sweats associated with menopause ; Decrease/reduce/relieve symptoms of menopause ; Decrease/reduce/relieve hot flushes associated with menopause ; Decrease/reduce/relieve aggression/irritability associated with menopause

Sommarju tal-prodott:

Visual Identification: ;

L-istatus ta 'awtorizzazzjoni:

Listed

Data ta 'l-awtorizzazzjoni:

2020-12-14